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The immune response to a large number of antigens, or antigenic determinants, has been
shown to be under genetic control (1-4) . Several control mechanisms have been
investigated . The antibody response linked to the immunoglobulin allotype is expressed in
the antibody-producing cells (5-9) and, at least in some cases, it may be controlled by a
structural gene for the immunoglobulin variable region (10) . The gene complex linked to
the major histocompatibility locus controls the response to many thymus-dependent
antigens (2, 11, 12) . The exact function of this locus is not yet known . It has been
suggested that the gene product is responsible for the recognition of the antigen by the
thymus-derived T cells (13) . Evidence has also been brought forward which is compatible
with the possible role of the gene product in the cooperation between T and B (the bone
marrow-derived) cells, or with a genetic defect at the level of the B cells only (14-17) .
Recent studies have led to the discovery of a linkage between the X-chromosome and the
level of the immune response to several antigens (18-20), which are mostly thymus-
independent . The control mechanism of the response is not known .
Synthetic polypeptides have been widely used in the study of the genetic control of the
immune response (1-4, 21) . Immunization with polypeptides built on multichain
polyalanine (A--L) leads to a response directed predominantly towards the determinants
attached to A- -L such as peptides oftyrosine and glutamic acid (T,G), phenylalanine and
glutamic acid (Phe,G), and histidine and glutamic acid (H,G) (22) . This response is linked
to the major histocompatibility locus of the mouse (H-2), and the gene complex
controlling the level of the response is called Ir-1A (23) .
The response to polypeptides built on multichain polyproline (Pro- -L) is controlled in a
more complex way . The antibody response to poly (LPhe,LGlu)-poly(LPro)--poly(ILys)
[(Phe,G)-Pro- -L ] is under the control of two separate genes . The ability to respond to the
(Phe,G) determinant is regulated by the Ir-1A gene which is linked to H-2, whereas the
response to the Pro- -L region of the molecule is controlled by a different gene, denoted
Ir-3, which is not linked to H-2 (24) . The capacity to elicit immune responses to
poly(LHis,LGlu)-poly(LPro)--poly(LLys), [(H,G)-Pro--L], is governed by at least three
immune response genes . The response potential to the (H,G) part of the immunogen is
controlled by the Ir-IA gene, a second gene (Ir-3) controls the response to Pro- -L, and a
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third gene controls the immune response to determinants characterized by a combination
of both the (H,G) and Pro- -L moieties. The last immune response gene(s) was found not
to be linked to H-2 (25). Upon immunization with poly(LTyr,LGlu)-poly(LPro)--
poly(LLys), [(T,G)-Pro--L], the specificity of the antibody elicited was found to be
directed exclusively towards Pro- -L, and the ability to mount an immune response to this
immunogen is governed by the Ir-3 gene (24, 26) . The Ir-3 gene is not linked either to the
H-2 locus, or to immunoglobulin allotypes (24), nor is it linked to the X-chromosome
(personal observation). The defect in the immune response of DBA/1, low responder mice
to (T,G)-Pro--L, has been shown to be expressed at the B-cell level, using the limiting
dilution analysis (27) and in experiments in which a thymus factor specific to
(T,G)-Pro--L was utilized (28, 29) .
Studies on the genetic control of immune response towards the synthetic multichain
antigens mentioned above have been carried out with animals immunized in complete
Freund's adjuvant. In such studies, the differences between low and high responder strains
were not reflected in the immunoglobulin class of the antibodies formed (30). On the other
hand, more recent studies of Grumet (31) have demonstrated that immunization of low
and high responder mice with an aqueous solution of poly(LTyr,LGlu)-poly(DLAla)--
poly(LLys),[(T,G)-A- -L], leads to antibody formation, and that the genetic defect is
expressed as inability of the low responder strain to produce IgG antibodies in a secondary
response.
In the present study, the appearance of the antibody-forming cells and of serum
antibody responses, after immunization with (T,G)-Pro- -L in aqueous solution
were investigated. The results show that there is no difference between the low
responder DBA/1 and high responder SJL strains, when they are immunized with
an optimal dose (1 ug) of antigen. With a higher dose of the immunogen, the
response in the high responder strain is higher than in the low responder strain,
whereas a suboptimal dose induces a higher response in the low responder than in
the high responder strain .
Materials and Methods
Animals. Mice of the inbred SJL and DBA/1 strains were obtained from the Experimental
Animal Unit of The Weizmann Institute. Mice of both sexes were used at 8-16 wk of age.
Antigens and Immunization Procedures. Poly(LTyr,LGlu)-poly(LPro--L)-poly(LLys), designated
(T,G)-Pro--L, 935, was used as the immunogen in this study. Poly(LPro)--poly(LLys),Pro--L, 927,
and poly(LTyr,LGlu)-poly(DLAla)--poly(LLys),(T,G)-A--L, 1383, were used in the inhibition of
plaque formation. The synthesis and characterization of these polypeptides have been described
earlier (32, 33) .
For the plaque-forming cell (PFC)' assay, mice were immunized intraperitoneally with different
doses of the antigen in 0.2 ml of phosphate-buffered saline (PBS, 0.15 M NaCI-0.01 M phosphate
buffer, pH 7.0). For the secondary response a booster injection was given 3 wk after the first
immunization, and for the tertiary response 6 wk after the second injection of the antigen. Antibodies
were titrated in the sera of animals immunized into the hind foot pads with different doses of antigen
in 0.06 ml of PBS.
Hemolytic Plaque-Forming Cell Assay.
￿
Plaque-forming cells were detected by the method of
Jeme et al. (34), using (T,G)-Pro- -L-coated sheep red blood cells (SRBC), as described earlier (35).
Indirect PFC were calculated by subtracting the number of direct plaques developed with the aid of
rabbit antimouse IgG serum which was prepared as described by Herzenberg and Herzenberg (36).
Inhibition of plaque formation was done according to Davie et al. (37) . Briefly, four different
concentrations of antigen (10-fold difference) were mixed with melted top agar, spleen cell
'Abbreviations used in thispaper: PBS, phosphate-buffered solution; PFC, plaque-forming cells.SEIJA JORMALAINEN, EDNA MOZES, AND MICHAEL SELA
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suspension, and antigen-coated SRBC immediately before plating. Percent of inhibition was
calculated for each concentration of antigen .
Antibody Titration.
￿
Antibodies were titrated by passive microhemagglutination (38), using fresh
SRBC which were coated with antigen using CrCl, as a coupling agent (39).
Tolerance Induction.
￿
In order to induce tolerance (T,G)-Pro- -L was injected in low and high
doses. For the low zone tolerance, mice were given 3 weekly injections ofthesupernate obtained after
centrifugation of the antigen at 15,000 rpm for 30 min. For the induction of the high zone tolerance,
mice were given one or two injections of the antigen in either centrifuged or not centrifuged form.
Results
Kinetics of Antibody-Forming Cell Response to Different Doses of An-
tigen. The number of direct and indirect PFC to (T,G)-Pro- -L in the spleens of
SJL high responder and DBA/1 low responder mice was followed during the
primary, secondary, and tertiary response to different doses of antigen given in
aqueous solution. The immune response to 1 kg of (T,G)-Pro- -L, which is
depicted in Fig. 1, was similar in both strains. The peak of direct PFC appeared 4
days after the first, second, and third injection of the antigen. In the secondary
response the number of direct PFC was higher and remained at a high level
longer than in the primary response. There was no significant difference in the
number of direct PFC between the strains.
When mice were immunized with a higher dose, 10 pg of (T,G)-Pro- -L, a
difference between the strains could be shown in two ways in the primary
response . In some experiments, shown in Fig. 2, both strains produced a similar
high number of direct plaques in the primary response, but the peak appeared 7
days later in the low responderDBA/1 strain than in the high responderstrain. In
some other experiments the difference between the strains was quantitative. The
high responder SJL mice produced a higher number of direct plaques than the
low responder mice . In the secondary response to this dose there was no
Ba.ckground~
FIG. 1.
￿
Kinetics of the direct hemolytic PFC response to 1 mg of (T,G)-Pro--L in SJL and
DBA/1 strains. Primary, secondary and tertiary responses. (O-O), SJL strain; ("--0),
DBA/1 strain. Each point represents the geometric means of five mice t SE.1060
￿
ANTIGEN DOSE AND GENETIC CONTROL OF RESPONSE
significant difference between these two strains either in the kinetics or in the
number of the direct PFC.
In the immune response to 100 Ng dose, which is shown in Fig. 3, both strains
produced a similar low number of plaques in the primary response . In the
secondary response the high responder SJL strain produced a four times higher
number of direct PFC than the low responder strain .
The production of indirect PFC by SJL and DBA/1 mice in the response to
(T,G)-Pro- -L given in aqueous solution was also investigated. The kinetics of the
secondary response to different doses of antigen is shown in Fig. 4. In the response
to 1 ,Ag dose no significant difference could be shown between the strains in the
number of plaques and in the appearance of the peak of the response. The
response to 10 Ag dose was lowerthan the response to 1,ug dose . No difference was
shown between the strains. In the response to 100 jug dose a quantitative
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FIG. 2.
￿
Kinetics of the direct hemolytic PFC response to 10 jug of (T,G)-Pro--L in SJL and
DBA/1 strains . Primary and secondary responses . (O-O), SJLstrain; ("-6), DBA/1 strain .
Each point represents the geometric means of five mice t SE.
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FIG. 3.
￿
Kinetics of the direct hemolytic PFC response to 100 lug of (T,G)-Pro--L in SJL and
DBA/1 strains. Primary and secondary responses (O-O), SJL strain; ("-0), DBA/1 strain.
Each point represents the geometric means of five mice t SE .FIG . 4.
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difference was shown between the strains . The high responder SJL mice
produced four times more indirect plaques than DBA/1 mice .
The indirect PFC response to the optimal 1 ug dose was followed in the
primary, secondary, and tertiary response . The results are summarized in Table
I . Both strains produced an equal number of indirect plaques already in the
primary response . The number of indirect plaques was higher in the secondary
than in the primary response . In the tertiary response to 1 lig dose both strains
produced an equally high number of indirect plaques, but a delay of 6 days was
Background.-
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Kinetics of the indirect hemolytic PFC responses to 1 lAg, 10 kg and 100 jug of
(T,G)-Pro--L in SJL and DBA/1 strains . Secondary response . (O-O), SJL strain ; (0-0),
DBA/1 strain . Each point represents the geometric means of five mice t SE .
TABLE I
Indirect Hemolytic Plaque-Forming Cells in the Primary,
Secondary and Tertiary Response to 1 gg of (T,G)-Pro--L
* Number of PFC per spleen, geometric means of five mice, standard
errors are in parentheses .
tThesecond injection of antigen wasgiven 3wk after the first injection .
§ The third injection ofantigenwasgiven 6 wk after the second injection .
Indirect
SJL
plaques
DBA/1
Exp. I
Primary response,day4 6,010* (1.23) 5,650 (1.24)
Secondary response,day4f 11,200 (1.14) 12,800 (1.14)
Exp. II
Secondary response, day4t 8,790 (1.25) 14,600 (1 .23)
Tertiary response §
Day4 2,330 (1.58) 440(l .33)
Day8 320 (1.33) 440(1 .07)
Day14 660 (1.58) 2,210 (1 .29)1062
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shown in the appearance of the peak of the response in the low responder DBA/1
strain.
Kinetics of the direct and indirect PFC response to a suboptimal dose of
(T,G)-Pro- -L, 0.02 hg, was followed in the primary and secondary response
(shown in Table II). In the primary response the low responder DBA/1 strain
produced 10 times more indirect plaques than the high responder strain. Also the
number of direct plaques was higher in the low responderstrain. As the result was
unexpected, the experiment was repeated several times and every time a 4-20
times higher number of indirect plaques was produced by the low responder
DBA/1 mice . In the secondary response no difference could be shown between the
strains in the number of direct or indirect plaques.
Antibody Titers in Sera . Mice were immunized with different doses of
antigen in aqueous solution into the hind foot pads. The results of the antibody
titrations by passive microhemagglutination are shown in Figs. 5-7. When mice
TABLE II
Direct and Indirect Hemolytic Plaque-Forming Cells in the Primary and
Secondary Response to 0.02 Ag of (TG)-Pro--L
* Number of PFC per spleen, geometric means of five mice, standard errors are in parentheses .
tThe second injection of antigen was given 3 wk after the first injection.
were immunized with 1 Ag of (T,G)-Pro- -L, both high and low responder mice
produced 2-mercaptoethanol (2-ME) resistant antibodies in the primary and
secondary response, slightly more being produced by the low responder strain
than high responder strain in the primary response. In the tertiary response the
titer of 2-ME resistant antibodies decreased in the low responderstrain (Fig. 5) .
In the primary response to the 10 hg dose, shown in Fig. 6, no significant
difference could be shown between the strains in the antibody titers, which were
low in both strains. In the secondary and tertiary response to this dose the total
antibody titers were higher in the high responder SJL mice than in DBA/1 mice.
In the secondary and tertiary response 2-ME-resistant antibodies could be
detected only in the high responder strain above the background level.
When mice were immunized into the foot pads with the 100 ug dose of
(T,G)-Pro- -L, (Fig. 7), the high responder mice produced higher amounts of
antibodies in the secondary response than the low responder DBA/1 mice. In the
tertiary response the total antibody titer increased in the high responder and
decreased in the low responder strain . With this dose the low responder mice did
not produce any detectable 2-ME-resistant antibodies .
Direct
SJL
PFC
DBA/1
Indirect
SJL
PFC
DBA/1
Primary response, day 4
Exp. I 4,320* (1.38) 9,920 (1 .10) 265(l .58) 4,985 (1.06)
Exp. II 3,100 (1.16) 6,950 (1 .19) 545(l .14) 2,100 (1 .10)
Exp.
11I
1,620 (1.63) 5,520 (1 .73) 400(l .19) 1,945 (1 .74)
Exp. IV 840 (1.29) 3,840 (1 .32) 68(l .63) 970(l .10)
Secondary response, day 4$
Exp. IV 1,290 (1.30) 1,830 (1 .21) 196(l .38) 510(l .20)SEIJA JORMALAINEN, EDNA MOZES, AND MICHAEL SELA
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Inhibition of Plaque Formation. Inhibition of the plaque formation with
(T,G)-Pro- -L was done on day 4 of the secondary response to the 1 jug dose, on
which day a similar numberofdirect and indirect plaques were produced by both
strains. The results are shown in Table III. Percent of direct and indirect PFC
inhibited by each concentration of free antigen was calculated . There was no
significant difference between the strains in the inhibition of direct or indirect
plaque formation by any concentration of antigen. Indirect plaques were
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FIG. 5. Hemagglutination titers in sera of SJL and DBA/1 mice immunized with 1 leg of
(T,G)-Pro--L in saline into the foot pads. (O-O), SJL, total antibody titer; ("-9), DBA/1,
total antibody titer; (O---O), SJL, 2-ME resistant antibody titer; ("---"), DBA/1 2-ME
resistant antibody titer. Each point represents a pool of five mice.
10
10 20 30 40 50
Time (days)
FIG. 6.
￿
Hemagglutination titers in sera of SJL and DBA/1 mice immunized with 10 jug of
(T,G)-Pro--L in saline into the foot pads. (O-0), SJL, total antibody titer; ("---0), DBA/1,
total antibody titer; (O---O), SJL, 2-ME resistant antibody titer; ("---"), DBA/1, 2-ME
resistant antibody titer. Each point represents a pool of five mice.1064
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inhibited more readily by free antigen than direct plaques in both strains.
Approximately a 10 times higher concentration of antigen was needed for the
inhibition of direct plaques than for the inhibition of indirect plaques.
In the primary response to the 0.02 leg dose, the inhibition of the plaque
formation was performed using (T,G,)-Pro- -L, Pro--L, and (T,G)-A- -L as
inhibitors (Table IV). This was done in order to test the possibility that, upon
immunization with 0.02 lag of (T,G)-Pro- -L, the DBA/1 mice would produce
antibodies to the (T,G) determinant, rather than to the Pro- -L region, as with
the higher doses used, antibodies were produced only to Pro--L. No inhibition
could be obtained with a micromolar concentration of (T,G)-A--L, whereas a 10
times lower concentration of (T,G)-Pro--L and Pro--L inhibited the hemolytic
0
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FIG. 7.
￿
Hemagglutination titers in sera of SJL and DBA/1 mice immunized with 100 kg of
(T,G)-Pro--L in saline into the foot pads. (O-O), SJL, total antibody titer; ("--0), DBA/1,
total antibody titer; (O---O), SJL, 2-ME resistant antibody titer; ("---"), DBA/1, 2-ME
resistant antibody titer. Each point represents a pool of five mice.
TABLE III
Inhibition of Hemolytic Plaque-Formation with the Free Antigen in the
Secondary Response to 1 ug of (TG)-Pro--L
* (T,G)-Pro--L used as inhibitor.
$ Percent of plaques inhibited with the given concentration ofinhibitor, meansoffive mice. Standard
errors are in parentheses.
Concn. of
Direct plaques Indirect plaques
inhibitor*
SJL DBA/1 SJL DBA/1
10-7 M 95.7 (=1.4)$ 98.2 (=1.0) 100 100
10-8 M 88.1 (=3.5) 95.5 (=2.5) 99.3 (= 0.5) 100
10-8 M 32.8 (=6.7) 42.8 (=6.7) 62.1 (=13.7) 70.1 (111.9)
10- `8 M 5.0 0-3.2) 17.6 (=3.9) 42.2(_ 8.7) 40.7 0=17.2)SEIJA JORMALAINEN, EDNA MOZES, AND MICHAEL SELA
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plaque formation to the background level. Thus, the specificity ofthe antibodies
was towards the Pro--L region.
Induction of Tolerance.
￿
For the induction of high zone tolerance, mice were
injected with different doses of (T,G)-Pro- -L which was not centrifuged orwith 1
mgofthe antigen in the centrifuged form . Booster injection, 1 Ug of(T,G)-Pro- -L
in saline, was given three wk after the first injection of the antigen (Table V). No
difference could be shown between the strains in the readiness to induce
tolerance. After two injections of deaggregated (T,G)-Pro- -L the PFC response
was reduced to the background level in both strains. To induce the low zone
tolerance, mice were injected three times a week with 1 ng of deaggregated
(T,G)-Pro- -L. Tolerance was obtained in both strains after seven injections of
the tolerogen (Table VI).
Discussion
The difference in antibody titers between the high and low responder mice to
(T,G)-Pro- -L was originally shown by experiments in which antigen was given in
complete Freund's adjuvant (24). The high responder strain produced higher
TABLE IV
Inhibition of Hemolytic Plaque-Formation with Different
Antigens in the Primary Response to 0.02,ug of (TG)-Pro--L
* Spleens of five mice were pooled.
TABLE V
Induction of High Zone Tolerance to (TG)-Pro--L
* Direct PFC response to 1 jug of (T,G)-Pro--L, which wasnotcentrifuged,
given 21 days after the first injection. Geometric means of five mice,
standard errors are in parentheses .
t Two injections of centrifuged (T,G)-Pro--L, 1 mg each, given at 7 days
interval.
Concn. of
inhibitor
Direct
SJL
plaques
DBA/1
Indirect
SJL
plaques
DBA/1
- 690* 3,120 116 1,210
10 - ' M (T,G)-Pro--L 90 60 40 177
10-7M Pro--L 60 45 88 178
10 - BM (T,G)-A--L 855 2,940 182 1,110
First injection of
(T,G)-Pro--L
Direct
SJL
plaques
DBA/1
200 ug 19,300 (1 .43)* 25,700 (1.15)
500 ug 14,200 (1 .26) 17,400 (1 .17)
1 mg 870(l .31) 1,110 (1.32)
1 mg (centrifuged) 750 (3.20) 280(l.25)
1 mg + 1 mg (centrifuged)$ 27(l .56) 21(l.29)1066
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TABLE VI
Induction of Low Zone Tolerance to (TG)-Pro--L
No. of
injections*
Direct plaques
SJL
￿
DBA/1
5
￿
9,100 (2.73)$
￿
34,400 (1.08)
7
￿
295(l.31)
￿
310(l.23)
* 1 ng of (T,G)-Pro--L, in a centrifuged form, given three times a week.
$ Direct PFC response to 1 ug of (T,G)-Pro--L, which was not centrifuged,
given 7 days afterthe last injection oftolerogen. Geometric means offive
mice, standard errors are in parentheses.
amounts of antibodies in the secondary response than the low responder strain.
The results described here show, however, that there is no difference in the
antibody titers and in the numbers of direct or indirect PFC in the primary and
secondary response between high and low responder mice when immunized with
1 gg, which appeared to be optimal dose, of antigen in aqueous solution (Fig. 1) .
When a higher than optimal dose was used for immunization, differences
between the strains could be shown. The immune response to 10 jug of
(T,G)-Pro- -L was lower in both strains than the response to the optimal dose. In
one experiment, which is shown in Fig. 2, the difference between the strains was
in the kinetics of the direct PFC, the peak of the response appearing later in the
low responder DBA/1 strain than in the high responder SJL strain. A difference
in the kinetics between the strains was also shown in the appearance of the peak
of indirect PFC in the tertiary response to the optimal 1 ug dose (Table 1) .
Similar differences in the kinetics of immune response between high and low responders
has been shown in the response of monkeys to the monkey herpes viruses (40). All monkeys
produced antibodies to the virus, but high responders, which do not develop tumors,
produced antibodies earlier than low responders, which do develop tumors. Green has also
noticed a difference in the time appearance of antibodies between guinea pig strains which
are responders or nonresponders to dinitrophenyl-polylysine (41) . After immunization
with a complex of DNP-poly-lysine and BSA, responder guinea pigs produced antibodies 5
days earlier than nonresponders .
A difference between the strains could also be shown in another way after immunization
with a high dose of antigen. In a few experiments, in which mice were immunized with 10
leg of antigen, a quantitative difference was shown between the strains in the number of
direct plaques in the primary response. Also in the secondary response to the 100 pg dose
the difference between the strains was quantitative (Fig. 3) . The high respondersproduced
a five times higher number of plaques than the low responders . Thus, the difference in the
kinetics of the PFC response and the quantitative difference in the actual number ofPFC
produced by the animal may represent the same basic difference between the strains, and
is possibly due to one single gene.
A quantitative difference between the strains could also be shown in the antibody titers .
After immunization with 10 Wg of antigen, a slight difference in the total antibody titers
was shown (Fig. 6) . The difference in the 2-ME-resistant antibodies was significant. In the
response to 100 ug of (T,G)-Pro- -L, both the total antibody titer and the 2-ME-resistant
antibody titerwere clearly higher in the high responder than in the low responder strain inSEIJA JORMALAINEN, EDNA MOZES, AND MICHAEL SELA
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the secondary and in the tertiary response (Fig . 7) . The difference in the antibody
formation between the high and low responder mouse strains injected with 10 ug of
(T,G)-Pro--L in complete Freund's adjuvant resembles the results reported here upon
immunization with 100 jig of antigen in aqueous solution . This is in agreement with
previous findings that the immune response to a small dose of an antigen in complete
Freund's adjuvant resembles in the kinetics and titers obtained the response to a much
higher dose administered in saline (42) .
The immune response to a suboptimal dose of antigen was unexpected, as a
higher response was obtained in the low responder strain than in the high
responder strain in the primary response . In all experiments the low responder
strain produced 4-20 times more indirect plaques than the high responder strain
(Table II) . The number of direct plaques was also higher in the low responder
strain in the primary response . The secondary response was not significantly
different in these two strains . That the dose may play a crucial role in defining
the genetic control of an immune response to a synthetic antigen, has been shown
previously by Dorf et al . (43) . They found that the immune response to GAT was
controlled by several genes. Besides the H-2-linked gene(s) which determines
whether a strain is a responder or a nonresponder, the non-H-2-linked genes
regulate the difference in the amounts of antibodies produced by the responder
strains . An H-2-linked genetic control in the response to a limiting dose of protein
antigen has been shown before (44, 45) . Recently, it has been shown that in the
response to LDH-H, mice strains of H-2s type are high responders to all doses,
mice of H-2".q type are responders to 100 pg dose but nonresponders to 10 jug and
mice of H-2k type are nonresponders to both doses of LDH-H, (Falkenberg and
Mozes, unpublished results) . In all the above studies, lowering the dose resulted
in a decreased response in the low responders whereas in this study the low
responders responded better to a low dose than the high responders, and 1 kg was
optimal for both strains.
It was of interest that in the primary and secondary response to the optimal dose both
strains produced equal numbers of indirect PFC (probably IgG-producing cells) . Also,
after immunization with 1 ug of antigen into the foot pads, 2-ME-resistant (probably IgG)
antibodies were found in both strains in the primary and secondary response. These
results are different from those reported by Grumet (31) for (T,G)-A- -L, an antigen to
which the immune response is H-2 linked. The low responders to (T,G)-A--L could not
produce IgG antibodies in the primary and secondary response by similar immunization.
Apparently, the mechanism of the low responsiveness to these two antigens is different. In
this context it is pertinent to point out the importance of macrophages in the response of
high and low responder mice to (T,G)-Pro- -L. The stimulation of peritoneal macrophages
increased the response in the low responder strain to the level of the high responder strain,
whereas the stimulation had no effect on the high responder strain (46). Similarly, the
injection of poly (A) -poly(U) corrected the response to (T,G)-Pro- -L in the low responder
strain, but it had no effect on the high responder strain (47) . In contradiction,
poly(A) -poly(U) (47) and macrophages (personal observation) do not affect the difference
in the response to (T,G)-A- -L by the high and low responder strains .
There are several possibilities to explain the difference seen between the strains
after immunization with a high dose of antigen . Such a dose could have a direct
suppressive effect on the antibody-producing cells or their precursors via the1068
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antigen-specific receptors. The specificity and affinity of such receptors have
been shown in some cases to be identical with the secreted antibodies (48) . Thus,
a more pronounced suppression found in the low responder strain wouldbe dueto
a higher avidity of the antigen specific receptors on B cells in the low responder
strain. This possibility was tested by inhibition of plaque formation by the free
antigen. The percent of cells inhibited by each concentration of antigen was
similar in both strains, suggesting that they have similar populations of high and
low avidity antibody-producing cells.
Another possible explanation for the difference between the strains would be a
qualitative difference of antigen-specific receptors on T cells. (T,G)-Pro- -L, used
as antigen, is thymus-dependent (3). A population of T cells with higher affinity
receptors for antigen might be triggered for antibody production as well as for
tolerance with a lower dose of antigen than another population having lower
affinity receptors, even if the antigen-specific receptors on B cells were identical
in the two strains. Thus, a higher response shown in the low responder DBA/1
strain to suboptimal dose of antigen might be explained by a higher affinity of the
T-cell receptors to (T,G)-Pro- -L in this strain. The high dose, which suppressed
the response more clearly in the low responder DBA/1 strain might do so by
inducing tolerance easier in this strain . To test this possibility, the low zone
tolerance, which has been shown to involve T cells only, as well as the high zone
tolerance, in which both T and B cells are tolerant (49), were induced in both
strains. No difference could be shown between the strains in the induction of
either high zone or low zone tolerance. These experiments suggest that the lower
response in the low responder DBA/1 strain to a higher than optimal dose of
antigen is not due to induction of tolerance more readily in this strain. As the
mechanism of tolerance induction is not known, no conclusion, however, can be
drawn concerning the T-cell receptor on the basis of this experiment. However,
the limiting dilution experiments (27) as well as the experiments in which a
T-cell factor specific to (T,G)-Pro- -L could be produced similarly in both high
responder SJL and low responder DBA/1 strains (29) indicate that the difference
between the strains in the response to this antigen is not due to a different quality
of antigen specific T-cell receptors but is expressed in B cells.
Further, the higher response obtained in the low responderthan high responder
strain after immunization with a low dose of antigen could be due to different
specificity of antibodies produced. Although both SJL and DBA/1 strains are low
responders to (T,G) determinant, when immunized with either (T,G)-Pro- -L or
(T,G)-A- -L in Freund's adjuvant, it was of interest to test whether thespecificity
of antibodies in the response to 0.02 pg of antigen given in aqueous solution was
really anti-Pro- -L and not directed towards the (T,G) part of the antigen. As no
inhibition could be obtained in the presence of (T,G)-A- -L, whereas
(T,G)Pro- -L and Pro- -L inhibited similarly the plaque formation, it is con-
cluded that the specificity of the antibodies was towards the Pro- -L region of the
antigen (Table IV).
The results of the present work suggest that the difference between SJL and
DBA/1 strains in the response to (T,G)-Pro--L, which is controlled by the Ir-3
gene, is not qualitative but quantitative. After immunization with the optimal
dose of antigen, there is equal stimulation (and probably also equal suppression)SEIJA JORMALAINEN, EDNA MOZES, AND MICHAEL SELA
￿
1069
in both strains . Afterimmunization with a higher than optimal dose of antigen the
suppression is more pronounced in the low responder strain, whereas with a
suboptimal dose the stimulatory effect is more clear in this strain . Several
explanations could be given to this phenomenon, and they all involve a
regulation between stimulation and suppression . Suppressor T cells have been
described recently in many reports (e.g . 50-52) . The first explanation is that the
ratio between stimulating and suppressingT cellswould be different in thesetwo
strains after injection of different doses of antigen . The second explanation is
that the amount of stimulating and suppressing factors produced by equal
numbers of cells in these strains would be different . The third and the most
appealing possibility is that the sensitivity of B cells to the stimulating and
suppressing effect ofT cells would be different in these twostrains in theresponse
to (T,G)-Pro- -L . Further experiments are currently under investigation in this
laboratory to test these possibilities .
Summary
Antibody response to different doses of (T,G)-Pro- -L, given in aqueous solution,
was investigated in the high responder SJL and low responder DBA/1 strains by
measuring hemolytic plaque-forming cells (PFC) in the spleens as well as
hemagglutination titers in the sera . The gene responsible for the difference
between the two strains in the response to this antigen, given in complete
Freund's adjuvant, has been previously denoted Ir-3 . This gene is not linked to
the major histocompatibility locus . In the response to the optimal dose (1 kg) of
antigen, no difference could be shown between the strains . The peak of the
response and the numbers of direct and indirect PFC were similar inboth strains
in the primary and secondary response . After injection of higher doses (10-100
ug) of antigen, both the direct and indirect PFC responses were lower in the low
responder than in the high responder strain . Moreover, the peak of the response
occurred earlier in the high responder strain in the primary response to the 10,ug
dose of antigen . After administration of a suboptimal dose (0.02 hg) of antigen,
the low responder strain produced in the primary response 4-20 times more
indirect plaques than the high responder strain . Also the number of direct
plaques was higher in the low responder than in the high responder strain . The
serum antibody responses to the optimal and higher doses of antigen were
parallel to the PFC responses .
From inhibition of PFC with free antigen, it was concluded that a similar
proportion of cells was producing high and low affinity antibodies to (T,G)-
Pro- -L in both strains . High and low zone tolerance could be induced in the two
strains with (T,G) -Pro- -L, but no difference could be shown between the strains .
It is suggested that the Ir-3 gene plays a role in the regulation of the balance
between stimulation and suppression according to the dose of antigen given.
Received for publication 10 December 1974 .
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